Amrutanjan Health Care Limited · NSE:AMRUTANJAN
Amrutanjan Health Care — Q1 FY26 Earnings Presentation
22 slides from Amrutanjan Health Care's earnings presentation, Aug 12, 2025
Slide 1: Stock exchange cover letter for investor presentation
AHCL/ SE/15 /2025-26 August 13, 2025 The National Stock Exchange of India Limited BSE Limited “Exchange Plaza”, C-1, Block G Department of Corporate Services Bandra-Kurla Complex, Bandra (E) 1st Floor, Mumbai 400 051 P.J. Towers, Dalal Street, Mumbai 400 001 Symbol: AMRUTANJAN Scrip Code: 590006 Dea
Slide 2: Investor Presentation Quarter Ended 30th June 2025
Amrutanjan Health Care Limited Investor Presentation Quarter Ended 30th June 2025 Date: 12th August 2025
Slide 3: Contents
Contents a. Business Update 1. Segment Performance 2. Activities 3. Operations b. Financials 1. Q1 FY26 Performance c. Management Commentary Investor Presentation | Quarter Ended 30th June 2025
Slide 4: Business Update
Business Update Investor Presentation | Quarter Ended 30th June 2025
Slide 5: AHCL Power Brands
AHCL Power Brands Brand Amrutanjan Pain Management: 63.0 Crs Women’s Congestion: 2.3 Crs Hygiene: 30.6 Crs Brand Relief Brand Comfy Rehydration: 8.7 Crs Brand Electro+ Note: Nos. given are Gross Sales Investor Presentation | Quarter Ended 30th June 2025
Slide 6: Q1 FY 25-26: Pain Management Growth is back!!
Q1 FY 25-26: Pain Management Growth is back!! “No Gain without Pain!!” Pain Management Congestion Women’s Hygiene Rehydration Brand Amrutanjan Brand Relief Brand Comfy Brand Electro+ Growth Q1 FY ‘26 Growth Q1 FY ‘26 Growth Q1 FY ‘26 Growth Q1 FY ‘26 Overall Pain Category 26% Relief Range 34% Overal
Slide 7: Segment Performance: Pain Management
Segment Performance: Pain Management Head Category (Brand Amrutanjan) Body Category (Brand Amrutanjan) Category Volume Growth is back: 6.8%* (MAT June 25) Vs. 1.2% MAT Amrutanjan’s Volume Growth is 24.6%* (Q1 FY26) and is higher than June 24 the category (8.2%). Value growth was also higher than the
Slide 8: Segment Performance: Congestion and Women's Hygiene
Segment Performance: Congestion and Women’s Hygiene Congestion (Brand Relief) Women’s Hygiene (Brand Comfy) Internal Growth Drivers (Q1 FY26 Vs. SPLY): Internal Growth Drivers: Comfy XL Variant 52% Relief Inhaler 40% Value Pack (18 Units Pack) 56% Relief Mint 89% Increase in XL Variant’s contributio
Slide 9: Consumer Engagement Activities: Head and Body
Consumer Engagement Activities: Head and Body Sampling: Pilgrimage Activity Activity Name : Puri Rathayatra Objective: To drive awareness and consideration Sampling in Pilgrimage Investor Presentation | Quarter Ended 30th June 2025
Slide 10: Marketing Interventions: Women's Hygiene
Marketing Interventions: Women’s Hygiene In-Store Activations: To Drive Awareness and Consideration • State: Andhra Pradesh, Telangana and Tamil Nadu • Objective: To build awareness and consideration at point of purchase • Placement: Nearly 20000 Outlets in these 3 states Comfy Sun Board Comfy A3 Po
Slide 11: Marketing Interventions: Rehydration Category
Marketing Interventions: Rehydration Category Consumer Education and Awareness Drive Category Education: • The penetration of rehydration solutions in India remains low (but with a fast pace growth) and category creation is critical • In addition, there is a misperception between WHO-formulated Oral
Slide 12: Marketing Interventions: Electro+
Marketing Interventions: Electro+ Consumer Awareness and Trials Investor Presentation | Quarter Ended 30th June 2025
Slide 13: Operations Update – Sales and Distribution
Operations Update – Sales and Distribution Distribution Sales Sales Infrastructure (Stockist Network) Lines Per Call Increased by 1% Increased by 2% Sales Infrastructure Manpower Productivity (Avg. Sub Stockist per Increased by 13% Super Stockist) Increased by 22% Avg. Productivity % Appointment of
Slide 14: Operations Update – HR
Operations Update – HR HR Initiatives Code of Conduct Training The code of conduct was updated by Sales /Product training for all using a thematic technique for easy our field employees (CSEs, ISRs understanding and HR had and ABMs) conducted communication sessions covering all employees Employee En
Slide 15: Financials
Financials Investor Presentation | Quarter Ended 30th June 2025
Slide 16: Financials – Q1 FY26
Financials – Q1 FY26 (Rs. in Crores) Net Sales Profit Before Tax Profit After Tax 94.05 11.29 83.74 8.31 6.35 4.62 Q1 FY26 Q1 FY25 Q1 FY26 Q1 FY25 Q1 FY26 Q1 FY25 Growth: 12.31% Growth: 77.80% Growth: 79.87% Particulars Q1 FY26 Q1 FY25 Growth Revenue from Operations 94.05 83.74 12.31% Less : Other O
Slide 17: Expenses – Q1 FY26
Expenses – Q1 FY26 (Rs. in Crores) Employee Benefit Expenses 16.01 13.86 Q1 FY26 Q1 FY25 Increase : 15.51% Advertisement & Selling Expenses Other Expenses 8.77 13.55 12.83 7.37 Q1 FY26 Q1 FY25 Q1 FY26 Q1 FY25 Decrease : 15.96% Decrease : 5.31% Investor Presentation | Quarter Ended 30th June 2025
Slide 18: Financials – Q1 FY26 (OTC and Comfy)
Financials – Q1 FY26 (Rs. in Crores) Net Sales - OTC Gross Sales - OTC 85.58 72.64 Particulars Q1 FY26 Q1 FY25 Growth Revenue from Operations 85.58 72.64 17.81% Less : Other Operating Revenue 0.13 0.18 Add : IND AS 115 adjustments 4.53 2.50 Add : GST 6.81 5.57 Gross Sales 96.79 80.53 20.19% Q1 FY26
Slide 19: Financials – Q1 FY26 (Beverages and Electro Plus)
Financials – Q1 FY26 (Rs. in Crores) Net Sales - Beverages Gross Sales - Beverages 10.96 7.76 Particulars Q1 FY26 Q1 FY25 Revenue from Operations 7.76 10.96 Less : Other Operating Revenue 0.02 0.06 Add : IND AS 115 adjustments 1.01 0.61 Add : GST 0.93 1.38 Q1 FY26 Q1 FY25 Gross Sales 9.69 12.88 Net
Slide 20: Management Commentary
Management Commentary Investor Presentation | Quarter Ended 30th June 2025
Slide 21: Management Commentary
Management Commentary 1. We saw the highest revenue numbers ever recorded in 1st quarter – driven by a robust growth from Pain Management category. 2. Pain management category especially in the head ache care segment saw a return to double digit volume growth. 3. This year we are focusing on market
Slide 22: Investor Presentation | Quarter Ended 30th June 2025
Investor Presentation | Quarter Ended 30th June 2025
Amrutanjan Health Care — Q1 FY26 Earnings Presentation on 6ix